CSF2 and acute myeloid leukemia: This study aimed to investigate the correlation between GM-CSF gene expression and different molecular prognostic markers such as FLT3-ITD, NPM1 mutation A and CEBPA gene expression in Egyptian acute myeloid leukemia patients.